Core Scientific Finalizes Cooperation Agreement with Major Shareholder Two Seas Capital, Announcing Board Changes
Summary
Core Scientific has finalized a cooperation agreement with major shareholder Two Seas Capital LP, detailing significant board changes and governance commitments.
Key Events
-
Cooperation Agreement Finalized
Core Scientific entered into a definitive cooperation agreement with Two Seas Capital LP, a significant shareholder. This follows the initial 8-K disclosure on February 18, 2026.
-
Board Composition Changes
The company will appoint three new independent directors: one by March 15, 2026, a second by September 15, 2026, and a third prior to the 2027 Annual Meeting.
-
Chairman Departure
Jordan Levy, the current Chairman of the Board, notified the company he will not stand for re-election at the 2026 Annual Meeting, citing a personal decision.
-
Shareholder Commitments
Two Seas Capital LP agreed to customary standstill provisions for one year and voting commitments until the 2027 Annual Meeting, supporting Board-nominated directors.
Analysis
This 8-K/A filing provides the definitive terms of the cooperation agreement between Core Scientific and Two Seas Capital LP, a significant shareholder. The agreement outlines substantial changes to the company's board composition, including the appointment of three new independent directors by the 2027 Annual Meeting and the current Chairman's decision not to seek re-election. This formalizes a resolution with a major investor, establishing governance stability and a clear path forward, which can be viewed positively by the market.
At the time of this filing, CORZ was trading at $17.53 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $5.4B. The 52-week trading range was $6.20 to $23.63. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.